<!DOCTYPE html>
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>

    <!-- Basic Page Needs
  ================================================== -->
	<meta charset="utf-8">
	<title>Times of Neurology</title>
	<meta name="description" content="Newsletter, Neurology,Epilepsy Designed by Medeka | medekahealth.com">
	<meta name="author" content="Neurology,Epilepsy">
	
    <!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    
  <!--   CSS
  ================================================== -->
  	<link rel="stylesheet" href="css/zerogrid.css">
		<link rel="stylesheet" href="css/style.css">
    <link rel="stylesheet" href="css/responsive.css">
	<link rel="stylesheet" href="css/responsiveslides.css" />
	
	<!--[if lt IE 8]>
       <div style=' clear: both; text-align:center; position: relative;'>
         <a href="http://windows.microsoft.com/en-US/internet-explorer/products/ie/home?ocid=ie6_countdown_bannercode">
           <img src="http://storage.ie6countdown.com/assets/100/images/banners/warning_bar_0000_us.jpg" border="0" height="42" width="820" alt="You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today." />
        </a>
      </div>
    <![endif]-->
    <!--[if lt IE 9]>
		<script src="js/html5.js"></script>
		<script src="js/css3-mediaqueries.js"></script>
	<![endif]-->
	
	<link href='./images/ton.ico' rel='icon' type='image/x-icon'/>
    <script src="js/jquery.min.js"></script>
	<script src="js/responsiveslides.js"></script>
	<script>
		$(function () {
		  $("#slider").responsiveSlides({
			auto: true,
			pager: false,
			nav: true,
			speed: 500,
			maxwidth: 962,
			namespace: "centered-btns"
		  });
		});
	</script>
	
	
</head>
<body>
<!--------------Header--------------->
<header>
	<div class="subnav">
		<div class="wrap-subnav zerogrid">
			<div class="links">
				<ul>
					<li><a href="index.html">Home</a></li>
					<li><a href="aboutus.html">About</a></li>
					<li><a href="contact.html">Contact</a></li>
				</ul>
			</div>
		</div>
	</div>
	<div class="wrap-header zerogrid">
		<div id="logo"><a href="#"><img src="./images/logo.png"/></a></div>
</header>

<nav>
	<div class="wrap-nav zerogrid">
		<div class="menu">
	<ul>
		<li><a href="SV.html">Sodium Valproate</a></li>
		<li><a href="DP.html">Clobazam</a></li>
		<li><a href="OXCB.html">Oxcarbazepine</a></li>
        <li><a href="OXCB_PM.html">Pregabalin</a></li>
        <li><a class="current" href="NN.html">Neurology News</a></li>        
	</ul>
		</div>
		
		<div class="minimenu"><div>TOPICS</div>
			<select onchange="location=this.value">
            <option value="index.html">Home</option>
				<option value="SV.html">Sodium Valproate</option>
				<option value="DP.html">Clobazam</option>
           		<option value="OXCB_HM.html">Hospital Coverage </option>     
				<option value="OXCB.html">Oxcarbazepine</option>
                <option value="OXCB_PM.html">Pregabalin</option>
                <option value="EXPO.html">Disease Perspective</option>
                <option value="NN.html">Neurology News</option>
                <option value="quiz.html">Neurology Quiz</option>
			</select>
		</div>
	</div>
</nav>

<!--------------Content--------------->
<section id="content">
	<div class="wrap-content zerogrid">
	  <div class="row">
		  <div id="main-content" class="col-2-3">
            <div class="wrap-col">
			  <article>
              <h2h><a href="NN.html">Neurology News</a></h2h>
              <br>
					 <ul><li> <h2>Treatment of focal epilepsy in children: A review of approved medications</h2>
						<span class="info">by medeka healthcare on october 01, 2013</a></span></li></ul>

			  </article>
					<article>
						<p>Arya et al. systematically reviewed clinical data
on efficacy/effectiveness of several antiepileptic
drugs as monotherapy and as adjunctive therapy
in the management of partial-onset seizures in
children.
The treatment of partial-onset seizures is vital as
the condition is a cause of significant concern in
childhood epilepsy. Therapeutic decision making
should consider several factors associated with the
drug, patient and their socioeconomic situation.
After reviewing various randomized clinical trials,
fMRI is a valuable noninvasive language
mapping tool for surgical planning of
epileptogenic foci and of brain tumors
Researchers from Switzerland demonstrated that
fast functional magnetic resonance imaging (fMRI)
reliably localizes the most relevant language areas
in individual patients who undergo surgery. Hence,
they proposed that fast fMRI could be a valuable
complementary tool for the surgical planning of
epileptogenic foci and of brain tumors.
fMRI was evaluated in an 8-minute auditory semantic
decision task in patients who had focal epilepsy or a
brain tumor (n=35) and in healthy controls (n=28).
Resective surgery was carried out in 19 patients.
Analysis were conducted individually and in
groups. Further, the outcomes were compared with
postsurgical language outcome and electrocortical
stimulation when available.
• In healthy controls, fMRI activations concordant
with the anterior and posterior language areas
were observed in 96 and 89% individuals,
respectively.
*Perucca E., CNS Drugs 2002; 16 (10): 695-714, **Robertson Human Psychopharmacology. 1995;10:S43-S63, ** Canadian Clobazam Cooperative group, Epilepsia, 1991 May-Jun; 32(3): 407-416.
The clinical updates provided in this newsletter is for information only. It may be possible that some information is out of approved label in India. Physicians are requested to refer the full prescribing information before using any product.
• Among patients who had focal epilepsy or a brain
tumor, the anterior and posterior language areas
were both activated in 93% of patients. Further,
the outcomes were concordant with electrocortical
stimulation results in 5 patients.
Transient postsurgical language deficits were displayed
in 2 patients in whom surgery was performed in the
vicinity of the fMRI activations or who had postsurgical
complications implicating areas of fMRI activations.
Reference
Genetti M, Grouiller F, Vulliemoz S, et al. Noninvasive language mapping
in patients with epilepsy or brain tumors. Neurosurgery. 2013;72(4):555-
65.
Role of dietary therapies in epilepsy
management
Since their introduction in 1921, the high-fat, lowcarbohydrate
‘ketogenic’ diets have been used worldwide
for refractory childhood epilepsy. The ketogenic diet is
reported to reduce seizures in at least 50% of children,
with epilepsy, and help 15% of epileptic children become
Arya et al. found that:<ul><li>As initial monotherapy, oxcarbazepine is the
only antiepileptic drug with Class I evidence for
efficacy in partial-onset seizures in children. Other
antiepileptic drugs, including carbamazepine,
clobazam, lamotrigine, phenobarbital,
phenytoin, topiramate, valproate, vigabatrin, and
zonisamide exhibited Class III efficacy evidence
for monotherapy of partial-onset seizures in
children.</li>
                            <li>For adjunctive therapy, gabapentin, lamotrigine,
levetiracetam, oxcarbazepine, and topiramate
displayed Class I efficacy evidence for the
treatment of pediatric partial-onset seizures.
Arya et al. recommended that physicians and patients
should integrate the efficacy data of an antiepileptic
drug with its safety and tolerability profile,
pharmacokinetic properties, available formulations,
and patient-specific characteristics when choosing
antiepileptic therapy in pediatric partial-onset
seizures.			  </li>
</ul>
<p>Arya et al. recommended that physicians and patients
should integrate the efficacy data of an antiepileptic
drug with its safety and tolerability profile,
pharmacokinetic properties, available formulations,
and patient-specific characteristics when choosing
antiepileptic therapy in pediatric partial-onset
seizures.</p>
<h11>References</h11>
                            <ul>
                            <li>Arya R, Glauser TA. Pharmacotherapy of Focal Epilepsy in Children:
A Systematic Review of Approved Agents. CNS Drugs. 2013;27(4):273-86.</li>
                          
                      </ul>
			  </article>
					<ul id="pagi">
						<li><a class="current" href="NN-I.html">1</a></li>
						<li><a href="NN-II.html">2</a></li>
                        <li><a href="NN-III.html">3</a></li>
					</ul>
					
		    </div>
            
       <p><br>
            <div class="featured">
	<div class="wrap-col">
		<div class="slider">
			<div class="rslides_container">
				<ul class="rslides" id="slider">
					<li><img src="images/slide07.jpg"/></li>
					<li><img src="images/slide15.jpg"/></li>
                  
				</ul>
			</div>
		</div>
	</div>
</div>     
	    </div>
			<div id="sidebar" class="col-1-3">
				<div class="wrap-col">
                <div class="box">
					  <div class="heading">
					    <h2>Contents</h2></div>
						<div class="content">
							<div class="linklist">
							  <ul><li><a href="IM.html">Initial monotherapy with levetiracetam fails more
frequently than monotherapy with valproate or
oxcarbazepine:</a>An enlightening evidence</li>
									<li><a href="SVpage_1.html">Sodium valproate:</a>A gold standard for the treatment of
childhood epilepsy</li>
									<li><a href="SVpage_2.html">Superior efficacy of sodium valproate IV reported in</a> acute seizures and status epilepticus</li>
									<li><a href="DP.html">Clobazam: </a>An effective long-term treatment option
for Lennox-Gastaut syndrome</li>
                                    <li><a href="OXCB_HM.html">Hospital coverage:</a>Krishna Institute of Medical Sciences</li>
                                <li><a href="OXCB.html">Oxcarbazepine:</a>A valuable treatment option for
partial-onset seizures in children</li>
                                      <li><a href="OXCB_PM.html">Pregabalin and methylcobalamin combination for
neuropathic pain:</a>The Indian scenario</li>
                                <li><a href="EXPO.html">Important aspects of epilepsy management:</a>during pregnancy</li>
                                    <li><a href="NN.html">Neurology News</a></li>
                                    <li><a href="quiz.html">Neurology Quiz</a></li>
                                    
								</ul>
							</div>
						</div>
				  </div>
                  <div class="box">
						<div class="heading"><h2>News Digest</h2></div>
						<div class="content">
							<div class="posts">
								<img src="images/post01.png"/>
								<h4><a href="#">ECG should be considered
in patients with refractory
epilepsy</a></h4><br>
									<p>Analysis of electrocardiogram
(ECG) monitoring
in patients with refractory
epilepsy revealed significant differences in
heart rate between ictal and pre-ictal states,
between ictal and post-ictal states, and
between pre- and post-ictal states. Hence,
ECG might be helpful to detect serious
cardiac abnormalities in patients with
refractory epilepsy.</p><p class="sideref">J Res Med Sci. 2013;18(Suppl 1):S32–4.</p>
							</div>
							<div class="posts">
								<img src="images/post02.png"/>
								<h4><a href="#">Use of gabapentin in pregnancy is not associated with increased risk of major malformations</a></h4><br>
							<p>A prospective study of
pregnancy outcomes in
223 pregnant women who were exposed to gabapentin and 223 pregnant women who were unexposed to gabapentin reported
that gabapentin use in pregnancy was not associated with increased risk for major malformations.</p> <p class="sideref">Epilepsy Behav. 2013;26(1):109–13.</p>
							</div>
							<div class="posts">
								<img src="images/post03.png"/>
								<h4><a href="#">A portable automatic device for the detection of generalized tonicclonic seizures</a></h4>
							<p>Increased S100B protein levels in cerebrospinal fluid may be associated with the neuronal damage following central nervous infections.</p>
							<p class="sideref">Epilepsia. 2013;54(4):e58–61.</p></div>
						</div>
				  </div>
					<div class="box">
						<div class="heading">
						  <h2>Updates</h2></div>
						<div class="content"> <img src="images/updates_add01.gif"/>						  <img src="images/updates_add02.gif"/>
						</div>
					</div>
				</div>
			</div>
	  </div>
  </div>
</section>
<!--------------Footer--------------->
<footer>
	<div class="copyright">
		<p>Copyright © 2013 Medekahealth.com - All rights reserved. | Design: <a href="http://www.medekahealth.com/">MedekaHealth.com</a><a href=</p>
	</div>
</footer>

</body></html>